Phase I trial to determine the effects of aspirin/omeprazole on gastric acid secretion in volunteers (Study 112).

Trial Profile

Phase I trial to determine the effects of aspirin/omeprazole on gastric acid secretion in volunteers (Study 112).

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Nov 2013

At a glance

  • Drugs Aspirin/omeprazole (Primary) ; Aspirin; Omeprazole
  • Indications Embolism and thrombosis; Ischaemic heart disorders; NSAID-induced ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 May 2012 Results presented at Digestive Disease Week 2012.
    • 22 May 2012 New trial record
    • 19 May 2012 Primary endpoint 'Time-with-intragastric-pH-greater-than-4' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top